Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2010
03/04/2010US20100055058 Use of stinging cells/capsules for the delivery of active agents to keratinous substances
03/04/2010US20100055044 Ruthenium compounds and compositions
03/04/2010US20100055042 Enhancing Clot Busting Medication in Stroke with Directed Drug Convection using Magnetic Nano-Particles
03/04/2010DE102008045339A1 Pharmazeutisches Pellet Pharmaceutical pellet
03/04/2010CA2735413A1 Microparticles
03/04/2010CA2735318A1 Nanoparticles for immunotherapy
03/03/2010EP2158923A1 Peg-urate oxidase conjugates and use thereof
03/03/2010EP2158922A1 Method for drying copolymers based on polyethers suitable as solubilisers for compounds which are hard to dissolve in water
03/03/2010EP2158920A1 Stabilizing alkylglycoside compositions and methods thereof
03/03/2010EP2158905A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158904A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158902A1 Ion binding compositions
03/03/2010EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy
03/03/2010EP2158899A1 Improved composition for the topical transmission of active ingredients into the human or animal body
03/03/2010EP2158898A1 Stabilizing alkylglycoside compositions and method thereof
03/03/2010EP2158223A2 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same
03/03/2010EP2157982A2 Amino acid lipids and uses thereof
03/03/2010EP2157970A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
03/03/2010EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof
03/03/2010EP2157864A2 Stabilized picoplatin dosage form
03/03/2010EP1959998B1 Copolymers based on polyalkylene oxide-modified n-vinyl lactam copolymers
03/03/2010EP1891102B1 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12
03/03/2010EP1569683B1 Modified natriuretic compounds, conjugates, and uses thereof
03/03/2010EP1404372B1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1
03/03/2010EP0852499B1 Therapeutic azide compounds
03/03/2010CN101659704A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
03/03/2010CN101658677A Lovastatin-sulfobutyl ether-beta-cyclodextrin inclusion compound, preparation and preparation method thereof
03/03/2010CN101658676A Novel cell targeted medicine delivery carrier, medicine composition containing same and method for delivering medicine by same
03/03/2010CN101658486A Hydrous external preparation containing sodium loxoprofen
03/03/2010CN100592920C Auxiliary materials of drop pills base material and manufacturing method of drop pills
03/03/2010CN100592908C Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
03/03/2010CN100592903C Stabilized natural cannabinoid formulation and preparation method thereof
03/02/2010USRE41157 Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
03/02/2010US7671095 Films and particles
03/02/2010US7671042 Pharmaceutical compositions containing cyclodextrins and taxoids
03/02/2010US7671036 Positively-charged peptide nucleic acid analogs with improved properties
03/02/2010US7671034 Controlling the amount of an already existing antioxidant or stabilizer; decrease or to prevent the formation of acid/base catalyzed decomposition of the active ingredient
03/02/2010US7671033 Amphiphilic dendritic dipeptides and their self-assembly into helical pores
03/02/2010US7671031 delivering an amphetamine by administering to said subject in need L-lysine-d-amphetamine or a salt thereof; providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity
03/02/2010US7671030 Administering L-lysine-d-amphetamine or salts
03/02/2010US7670626 Encapsulated bioactive bisphosphonate such as alendronate including mono- or diglyceride of caproic or capric acid enhancer or surfactant comprising ethylene oxide-propylene oxide block copolymer
03/02/2010US7670625 Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent
03/02/2010US7670617 Sequential drug delivery systems
03/02/2010US7670606 Method for administering a vaginal care composition
03/02/2010US7670605 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/02/2010US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab
03/02/2010US7670592 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
03/01/2010CA2640879A1 Liquid formulation containing a taxane derivative
02/2010
02/28/2010CA2676585A1 Improved composition for the topical transmission of active ingredients into the human or animal body
02/25/2010WO2010022320A2 Polymeric benzyl carbonate-derivatives
02/25/2010WO2010022193A2 Hot-melt extrusion of modified release multi-particulates
02/25/2010WO2010022051A2 Disruptors of early/recycling endosomes
02/25/2010WO2010021770A1 Heterogeneous polymeric micelles for intracellular delivery
02/25/2010WO2010021720A1 Conjugates of small-interfering nucleic acids
02/25/2010WO2010021718A1 Complexes of small-interfering nucleic acids
02/25/2010WO2010021570A1 Method for immobilising biologically active substances on polymer carriers (variants) and conjugates produced by said method
02/25/2010WO2010021555A1 Anthelmintic compositions
02/25/2010WO2010021320A1 Apparatus for producing vesicles having even diameters and process for producing the vesicles
02/25/2010WO2010021300A1 Novel excipient for mannitol tableting
02/25/2010WO2009156677A3 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative
02/25/2010WO2009152041A3 Controlled release formulations of pramipexole
02/25/2010WO2009149058A3 Modified release niacin formulations
02/25/2010WO2009140421A3 Polymeric carrier
02/25/2010WO2009133455A3 Pharmaceutical composition of clodipogrel
02/25/2010WO2009129494A4 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
02/25/2010WO2009129460A3 Clonidine formulations in a biodegradable polymer carrier
02/25/2010WO2009086067A3 Particles for injection and processes fo forming the same
02/25/2010WO2009077599A3 Nanospheres with external surface of noble metal
02/25/2010WO2009036092A9 Mitochondria-targeted anti-tumour agents
02/25/2010WO2009031006A3 Antiviral topical formulations in the form of a bio-adhesive gel
02/25/2010WO2009030205A3 Gelatine-active ingredient conjugates
02/25/2010WO2009016181A3 Optical imaging agents
02/25/2010US20100049080 Thixotropic swallow challenge medium
02/25/2010US20100048872 Methods for making proteins containing free cysteine residues
02/25/2010US20100048739 Surface-active material and its applications
02/25/2010US20100048737 Cosmetic preparations based on molecularly imprinted polymers
02/25/2010US20100048736 Anionic charge-dynamic polymers for release of cationic agents
02/25/2010US20100048735 Polyaminoacids functionalized wtih alpha-tocopherol, and uses thereof, especially therapeutic uses
02/25/2010US20100048734 Hydrophilic copolymers and assemblies containing the same
02/25/2010US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c
02/25/2010US20100048659 Aqueous compositions containing metronidazole
02/25/2010US20100048526 Pharmaceutical composition for transdermal or transmucous administration
02/25/2010US20100048490 Binding ligand linked drug delivery conjugates of tubulysins
02/25/2010US20100048472 Albumin Fusion Proteins
02/25/2010US20100048451 Novel spill-resistant formulations comprising hydrocolloidal polymers
02/25/2010US20100047435 Hydrogel Attached to Backing and Method for Making Same
02/25/2010US20100047364 Nutrient System for Individualized Responsive Dosing Regimens
02/25/2010US20100047337 Pharmaceutical spheroids
02/25/2010US20100047334 Ph sensitive liposome compositions for controlling surface topography and binding reactivity in functionalized liposomes
02/25/2010US20100047325 Analgesic anti-inflammatory patches for topical use
02/25/2010US20100047279 Immunological composition
02/25/2010US20100047248 Methods of processing compositions containing microparticles
02/25/2010US20100047223 Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
02/25/2010US20100047215 Stem cell targeting methods
02/25/2010US20100047206 Powdery composition for nasal administration
02/25/2010US20100047196 Novel microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics
02/25/2010US20100047175 Sincalide Formulations
02/25/2010US20100047169 NK Cell Receptor Conjugates for Treating Malignancies
02/25/2010CA2734917A1 Heterogeneous polymeric micelles for intracellular delivery
02/25/2010CA2734847A1 Novel excipient for mannitol tableting
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 1712